PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HIVE vs. MARA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HIVE and MARA is 0.66, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.7

Performance

HIVE vs. MARA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in HIVE Blockchain Technologies Ltd (HIVE) and Marathon Digital Holdings, Inc. (MARA). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%AugustSeptemberOctoberNovemberDecember2025
-3.39%
-2.87%
HIVE
MARA

Key characteristics

Sharpe Ratio

HIVE:

-0.33

MARA:

-0.27

Sortino Ratio

HIVE:

0.07

MARA:

0.31

Omega Ratio

HIVE:

1.01

MARA:

1.03

Calmar Ratio

HIVE:

-0.32

MARA:

-0.32

Martin Ratio

HIVE:

-0.97

MARA:

-0.79

Ulcer Index

HIVE:

29.89%

MARA:

37.21%

Daily Std Dev

HIVE:

87.91%

MARA:

107.04%

Max Drawdown

HIVE:

-97.72%

MARA:

-99.74%

Current Drawdown

HIVE:

-88.37%

MARA:

-88.14%

Fundamentals

Market Cap

HIVE:

$402.61M

MARA:

$6.22B

EPS

HIVE:

-$0.13

MARA:

$0.83

Total Revenue (TTM)

HIVE:

$91.61M

MARA:

$441.98M

Gross Profit (TTM)

HIVE:

-$1.78M

MARA:

-$109.55M

EBITDA (TTM)

HIVE:

$43.68M

MARA:

$295.10M

Returns By Period

In the year-to-date period, HIVE achieves a 9.47% return, which is significantly higher than MARA's 6.90% return.


HIVE

YTD

9.47%

1M

-22.77%

6M

-3.41%

1Y

-25.71%

5Y*

47.74%

10Y*

N/A

MARA

YTD

6.90%

1M

-23.10%

6M

-2.87%

1Y

-28.69%

5Y*

81.91%

10Y*

-17.54%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HIVE vs. MARA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIVE
The Risk-Adjusted Performance Rank of HIVE is 3131
Overall Rank
The Sharpe Ratio Rank of HIVE is 3030
Sharpe Ratio Rank
The Sortino Ratio Rank of HIVE is 3636
Sortino Ratio Rank
The Omega Ratio Rank of HIVE is 3636
Omega Ratio Rank
The Calmar Ratio Rank of HIVE is 2828
Calmar Ratio Rank
The Martin Ratio Rank of HIVE is 2626
Martin Ratio Rank

MARA
The Risk-Adjusted Performance Rank of MARA is 3535
Overall Rank
The Sharpe Ratio Rank of MARA is 3333
Sharpe Ratio Rank
The Sortino Ratio Rank of MARA is 4343
Sortino Ratio Rank
The Omega Ratio Rank of MARA is 4141
Omega Ratio Rank
The Calmar Ratio Rank of MARA is 2828
Calmar Ratio Rank
The Martin Ratio Rank of MARA is 3131
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HIVE vs. MARA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for HIVE Blockchain Technologies Ltd (HIVE) and Marathon Digital Holdings, Inc. (MARA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for HIVE, currently valued at -0.33, compared to the broader market-4.00-2.000.002.00-0.33-0.27
The chart of Sortino ratio for HIVE, currently valued at 0.07, compared to the broader market-4.00-2.000.002.004.000.070.31
The chart of Omega ratio for HIVE, currently valued at 1.01, compared to the broader market0.501.001.502.001.011.03
The chart of Calmar ratio for HIVE, currently valued at -0.32, compared to the broader market0.002.004.006.00-0.32-0.36
The chart of Martin ratio for HIVE, currently valued at -0.97, compared to the broader market-10.000.0010.0020.00-0.97-0.79
HIVE
MARA

The current HIVE Sharpe Ratio is -0.33, which is comparable to the MARA Sharpe Ratio of -0.27. The chart below compares the historical Sharpe Ratios of HIVE and MARA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50AugustSeptemberOctoberNovemberDecember2025
-0.33
-0.27
HIVE
MARA

Dividends

HIVE vs. MARA - Dividend Comparison

Neither HIVE nor MARA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

HIVE vs. MARA - Drawdown Comparison

The maximum HIVE drawdown since its inception was -97.72%, roughly equal to the maximum MARA drawdown of -99.74%. Use the drawdown chart below to compare losses from any high point for HIVE and MARA. For additional features, visit the drawdowns tool.


-90.00%-85.00%-80.00%-75.00%-70.00%-65.00%AugustSeptemberOctoberNovemberDecember2025
-88.37%
-75.89%
HIVE
MARA

Volatility

HIVE vs. MARA - Volatility Comparison

The current volatility for HIVE Blockchain Technologies Ltd (HIVE) is 22.52%, while Marathon Digital Holdings, Inc. (MARA) has a volatility of 26.72%. This indicates that HIVE experiences smaller price fluctuations and is considered to be less risky than MARA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


15.00%20.00%25.00%30.00%35.00%40.00%45.00%50.00%AugustSeptemberOctoberNovemberDecember2025
22.52%
26.72%
HIVE
MARA

Financials

HIVE vs. MARA - Financials Comparison

This section allows you to compare key financial metrics between HIVE Blockchain Technologies Ltd and Marathon Digital Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab